Special pathological reporting is necessary in patients undergoing neoadjuvant systemic therapy (NST). There exist a minimum of 5 distinct reporting scores to the grade of remission right after NST; A few of these, however, are only validated for inflammatory breast cancer (e.need to be regarded as for the particular treatment selection. The tips a